Company intelligence / Profile preview

Magellan Discovery Technologies

Maryland, United States

Ownership: Private
Development stage: Other

Overview

Magellan Discovery Technologies, LLC was a private life sciences acquisition and investment company active in the early 2000s. Led by President and CEO Robert J. Rosenthal, Ph.D., the firm focused on identifying and acquiring promising drug discovery tools and medical technologies. It served as a precursor and strategic vehicle for the formation of Magellan Biosciences, which later became a significant provider of clinical diagnostics and life science research tools. The company is no longer active, having fulfilled its role in the consolidation and development of the Magellan group of companies.

Industry: Investors

Beyond the preview

Go deeper on Magellan Discovery Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magellan Discovery Technologies.

Explore the full profile